Xue, Yu-Hua <br/><br/>
Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Dec 2010 
 - 2012-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.23942  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Female<br/>Focal Adhesion Kinase 1--metabolism<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Osteopontin--physiology<br/>Prognosis<br/>Thrombin--drug effects